Cerebrospinal-fluid profile in neuroborreliosis and its diagnostic significance
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
17455797
DOI
10.1007/bf02931625
Knihovny.cz E-zdroje
- MeSH
- Borrelia burgdorferi komplex * imunologie MeSH
- diferenciální diagnóza MeSH
- hematoencefalická bariéra MeSH
- histocytochemie MeSH
- imunoglobulin G mozkomíšní mok MeSH
- imunoglobulin M mozkomíšní mok MeSH
- lidé MeSH
- lymská neuroborelióza mozkomíšní mok diagnóza MeSH
- mozkomíšní mok * chemie cytologie imunologie MeSH
- nemoci nervového systému mozkomíšní mok diagnóza MeSH
- protilátky bakteriální mozkomíšní mok MeSH
- sérový albumin mozkomíšní mok MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- imunoglobulin G MeSH
- imunoglobulin M MeSH
- protilátky bakteriální MeSH
- sérový albumin MeSH
Selected cerebrospinal-fluid (CSF) parameters (intrathecal synthesis of Borrelia-specific antibodies, oligoclonal IgG bands, CSF-to-serum quotient of albumin as a marker of blood-CSF barrier function and cytology) and typical CSF profile in neuroborreliosis were evaluated with the aim of elucidating possible clinical and laboratory similarities of neuroborreliosis (NB) and other neurological diseases (OND). From the cohort of 58 patients (38 diagnosed for NB, 20 with OND) NB patients had positive Borrelia-specific IgG antibodies in 97 % and positive Borrelia-specific IgM antibodies in 55 %; oligoclonal IgG bands were detected in 55%. The blood-CSF barrier was impaired in 89%, positive cytology was detected in 97% of the NB patients. Evaluation of specific intrathecal synthesis improves CSF diagnosis of NB, therefore, a combined CSF analysis has to be considered along with the clinical picture and medical history when formulating the diagnosis of NB.
Zobrazit více v PubMed
Acta Neurol Scand. 2002 Oct;106(4):205-8 PubMed
Neurology. 1995 Sep;45(9):1663-70 PubMed
Folia Microbiol (Praha). 2005;50(3):229-38 PubMed
J Clin Microbiol. 1994 Jun;32(6):1519-25 PubMed
Folia Microbiol (Praha). 2004;49(3):297-300 PubMed
Clin Chim Acta. 2003 Aug;334(1-2):107-10 PubMed
J Neurol. 1998 May;245(5):262-72 PubMed
J Neurol. 2003 Mar;250(3):371-2; author reply 372 PubMed
Mult Scler. 1998 Jun;4(3):99-107 PubMed
Adv Clin Chem. 2001;36:1-62 PubMed
J Neurol Sci. 2001 Mar 1;184(2):101-22 PubMed
Folia Microbiol (Praha). 2005;50(1):31-9 PubMed
J Clin Microbiol. 2000 Jun;38(6):2097-102 PubMed
Acta Neurol Scand. 2001 Aug;104(2):72-7 PubMed
Clin Chem Lab Med. 2003 Mar;41(3):331-7 PubMed
Sb Lek. 2003;104(1):1-12 PubMed
Folia Microbiol (Praha). 2003;48(6):849-55 PubMed
J Neurol. 1994 Dec;242(1):26-36 PubMed
Clin Chem. 1991 Jul;37(7):1153-60 PubMed
Folia Microbiol (Praha). 2003;48(6):839-47 PubMed
J Neurol. 1998 May;245(5):247-55 PubMed
Scand J Infect Dis. 2002;34(6):421-5 PubMed
Acta Cytol. 2001 Jan-Feb;45(1):51-9 PubMed
Acta Neurol Scand. 2000 Feb;101(2):89-94 PubMed
Folia Microbiol (Praha). 2005;50(5):457-63 PubMed
Analysis of cerebrospinal fluid cell populations with monoclonal antibodies
